Compare Exelixis (EX9) vs. Competitors

3 Followers

Comparison Results

EX9

Exelixis

―

CHF12.15B

17.73

3 Buy

9 Hold

1 Sell

Hold

Incyte

$128.12

$23.13B

13.87

30.14%

11 Buy

10 Hold

0 Sell

Moderate Buy

Jazz Pharmaceuticals

$260.23

$15.32B

15.22

68.36%

18 Buy

1 Hold

0 Sell

Strong Buy

Summit Therapeutics

$14.23

$13.78B

-15.46

-19.47%

10 Buy

6 Hold

0 Sell

Moderate Buy

Zai Lab

$26.82

$2.76B

-15.21

-23.05%

3 Buy

0 Hold

0 Sell

Strong Buy

Genmab

$34.36

$21.35B

29.18

12.29%

9 Buy

1 Hold

0 Sell

Strong Buy

xxxxxxxxxxxxx

EX9 vs GMAB

xxxxxxxxxxxxx

Performance Comparison

CH:EX9

Exelixis

―

INCY

Incyte

113.44

28.06

32.86%

JAZZ

Jazz Pharmaceuticals

231.19

93.41

67.80%

SMMT

Summit Therapeutics

17.95

-5.39

-23.09%

ZLAB

Zai Lab

25.31

-8.38

-24.87%

GMAB

Genmab

36.65

3.91

11.94%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >